🇺🇸 FDA
Patent

US 7928107

Quinazolines useful as modulators of ion channels

granted A61PA61P19/02A61P25/00

Quick answer

US patent 7928107 (Quinazolines useful as modulators of ion channels) held by Vertex Pharmaceuticals Incorporated expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P19/02, A61P25/00, A61P25/06, A61P25/08